Discovery is major step towards a stem cell replacement therapy for Duchenne Muscular Dystrophy
UCLA scientists have developed a new strategy to efficiently isolate, mature and transplant skeletal muscle cells created from human pluripotent stem cells, which can produce all cell types of the body. The findings are a major step towards developing a stem cell replacement therapy for muscle diseases including Duchenne Muscular Dystrophy, which affects approximately 1 in 5,000 boys in the U.S. and is the most common fatal childhood genetic disease.
The study was published in the journal Nature Cell Biology by senior author April Pyle, associate professor of microbiology, immunology and molecular genetics and member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. Using the natural human development process as a guide, the researchers developed ways to mature muscle cells in the laboratory to create muscle fibers that restore dystrophin, the protein that is missing in the muscles of boys with Duchenne.
Without dystrophin, muscles degenerate and become progressively weaker. Duchenne symptoms usually begin in early childhood; patients gradually lose mobility and typically die from heart or respiratory failure around age 20. There is currently no way to reverse or cure the disease.
For years, scientists have been trying different methods that direct human pluripotent stem cells to generate skeletal muscle stem cells that can function appropriately in living muscle and regenerate dystrophin-producing muscle fibers. However, the study led by Pyle found that the current methods are inefficient; they produce immature cells that are not appropriate for modeling Duchenne in the laboratory or creating a cell replacement therapy for the disease.
“We have found that just because a skeletal muscle cell produced in the lab expresses muscle markers, doesn’t mean it is fully functional,” said Pyle. “For a stem cell therapy for Duchenne to move forward, we must have a better understanding of the cells we are generating from human pluripotent stem cells compared to the muscle stem cells found naturally in the human body and during the development process.”
By analyzing human development, the researchers found a fetal skeletal muscle cell that is extraordinarily regenerative. Upon further analysis of these fetal muscle cells two new cell surface markers called ERBB3 and NGFR were discovered; this enabled the reserchers to precisely isolate muscle cells from human tissue and separate them from various cell types created using human pluripotent stem cells.
Once they were able to isolate skeletal muscle cells using the newly identified surface markers, the research team matured those cells in the lab to create dystrophin-producing muscle fibers. The muscle fibers they created were uniformily muscle cells, but the fibers were still smaller than those found in real human muscle.
“We were missing another key component,” said Michael Hicks, lead author of the study. The skeletal muscle cells were not maturing properly, he explained. “We needed bigger, stronger muscle that also had the ability to contract.”
Once again, the team looked to the natural stages of human development for answers. Hicks discovered that a specific cell signaling pathway called TGF Beta needs to be turned off to enable generation of skeletal muscle fibers that contain the proteins that help muscles contract. Finally, the team tested their new method in a mouse model of Duchenne.
“Our long term goal is to develop a personalized cell replacement therapy using a patient’s own cells to treat boys with Duchenne,” said Hicks. “So, for this study we followed the same steps, from start to finish, that we’d follow when creating these cells for a human patient.”
First, the Duchenne patient cells were reprogrammed to become pluripotent stem cells. The researchers then removed the genetic mutation that causes Duchenne using the gene editing technology CRISPR-Cas9. Using the ERBB3 and NGFR surface markers, the skeletal muscle cells were isolated and then injected into mice at the same time a TGF Beta inhibitor was administered.
“The results were exactly what we’d hoped for,” said Pyle. “This is the first study to demonstrate that functional muscle cells can be created in a laboratory and restore dystrophin in animal models of Duchenne using the human development process as a guide.”
Further research will focus on generating skeletal muscle stem cells that can respond to continuous injury and regenerate new muscle long-term using the team’s new isolation and maturation strategy.
The Latest on: Duchenne Muscular Dystrophy
Richard Linklater and PETA Fight Texas A&M’s Experiments on Dogs With Muscular Dystrophy — Exclusive
on June 13, 2018 at 6:11 am
[Duchenne muscular dystrophy] is a devastating disease that affects both children and dogs. It is a genetic disease that affects boys, all of whom die early in life, living only into their twenties, but only after much suffering. Any parent with an ... […]
Limitless: Young man with muscular dystrophy shows courage in the face of hardship
on June 9, 2018 at 1:17 pm
Logan Shannon was just 10 years old when Duchenne muscular dystrophy took over his body. The condition is a genetic disorder that leads to muscle degeneration and weakness. But despite the grim diagnosis, the Cincinnati native is showing others how to stay ... […]
Duchenne Muscular Dystrophy Market Estimated to Flourish at by 2026
on June 7, 2018 at 6:26 am
Duchenne Muscular Dystrophy (DMD) is one of the most common types of genetic disorder that results in muscle degeneration. Currently there is no curative treatment for DMD, however, various organizations are investing in the research and development, in ... […]
Disease spotlight: Duchenne muscular dystrophy (DMD)
on June 5, 2018 at 9:55 am
Duchenne muscular dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness. Duchenne is a rare disorder, but among genetic conditions it is one of the most frequently seen. Duchenne affects around 1 in 3,500 male ... […]
Upgrading the toolbox for Duchenne muscular dystrophy research with a new rabbit model
on June 4, 2018 at 7:40 am
Research to improve our understanding of Duchenne muscular dystrophy (DMD), and the development of new therapies, has previously relied on mouse models. However, physiological differences between the two species has limited how successfully findings in ... […]
9-Year-Old Boy With Muscular Dystrophy Hugs...
on June 3, 2018 at 8:58 pm
Laura revealed that when Jordan was almost four years old, he was diagnosed with Duchenne muscular dystrophy, a fatal muscle-wasting disease that affects approximately one in 3,500 boys. More than five years later, Jordan is part of a clinical trial and he ... […]
Memphis firefighters raise thousands to fight muscular dystrophy
on June 2, 2018 at 3:08 pm
Dalton was diagnosed with Duchenne muscular dystrophy at 6 years old. He stopped walking at 9. Through it all, "he's the toughest kid in the whole wide world," his mother said. Last year, the Memphis firefighters raised $71,000 for the Muscular ... […]
Kelly: Bellevue University grad with muscular dystrophy goes ‘against all the odds’
on June 1, 2018 at 11:31 pm
Most will walk. Derek Caster, 23, who has Duchenne muscular dystrophy, will make the trip in what he calls his “fancy power wheelchair.” His high school graduation from Papillion-La Vista South was poignant, and he says his college commencement ... […]
Branchburg resident to run 35 miles for Duchenne Muscular Dystrophy awareness
on June 1, 2018 at 3:18 am
Branchburg resident to run 35 miles for Duchenne Muscular Dystrophy awareness When deciding what to do for his 35th birthday, Bobby Howland decided to celebrate by raising money for Duchenne Muscular Dystrophy. Check out this story on mycentraljersey.com ... […]
via Google News and Bing News